SEC 13F Intelligence

Bios Capital Management, LP / ACTU

Bios Capital Management, LP’s Actuate Therapeutics Inc Position

Does Bios Capital Management, LP own Actuate Therapeutics Inc (ACTU)? Yes — 10.05M shares worth $28M (+52.09% of its 13F portfolio) as of Q1 2026.

Position Value
$28M
Q1 2026
Shares
10.05M
% of Portfolio
+52.09%
Quarters Held
6
currently held

Position History ACTU

Reported value by quarter
Q4 ’24: $79MQ4 ’24Q1 ’25: $67MQ1 ’25Q2 ’25: $61MQ2 ’25Q3 ’25: $67MQ3 ’25Q4 ’25: $62MQ4 ’25Q1 ’26: $28MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202610.05M$28M+52.09%
Q4 202510.05M$62M+74.44%
Q3 202510.05M$67M+75.62%
Q2 20259.97M$61M+83.89%
Q1 20259.89M$67M+84.59%
Q4 20249.89M$79M+83.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bios Capital Management, LP’s full portfolio or all institutional holders of ACTU.